Auristone was proud to present a poster titled “Transcriptomic analysis of HER2 expression in metastatic breast cancer: Insights from a UAE patient cohort” at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025.

This study, conducted in collaboration with Dr Shaheenah Dawood, explored HER2 expression patterns using transcriptomic analysis in real-world metastatic breast cancer samples from the UAE. The findings contribute to a deeper understanding of HER2 biology beyond conventional diagnostics and demonstrate the value of transcriptomic and epigenomic insights in guiding precision oncology approaches.

ASCO continues to serve as a key platform for Auristone to share research, engage with the global oncology community, and advance the clinical integration of epigenomic technologies.